top of page
Image by Glenn Carstens-Peters

Álvaro Martínez Mateu

This is my professional blog, where I share my knowledge about Paid Media and Digital Marketing, along with the trends that shape this field.  I hope you find what I have written useful.




Spending on paid media can determine the success or failure of your digital marketing strategies. Deciding how much to invest isn’t about picking a random number but rather balancing your goals and having a clear understanding of Cost Per Action (CPA) and Customer Lifetime Value (CLTV). A well-structured approach will allow you to establish a sustainable foundation for growth.


The starting point is to define what you want to achieve. Your goals will dictate how much you need to invest. For instance, a startup aiming for rapid growth might afford a higher initial spend, whereas an established business will prioritise sustained profitability.


CPA is a key metric. Spending between 5 and 15 times your CPA is common practice, although certain scenarios may justify deviations. For example, in the luxury market, where customers have a very high CLTV, it may be acceptable to invest 20 to 25 times the initial CPA to acquire exclusive customers. In contrast, a startup in a testing phase might limit spending below the common range to collect data without straining cash flow. A business with a high CLTV can justify greater spending as the long-term return outweighs the cost. Conversely, for an e-commerce business with tight margins, exceeding this proportion could jeopardise viability.


Highly competitive markets also require greater investment. For example, sectors like enterprise SaaS might justify spending up to 100 times the CPA if client relationships are long-lasting, CLTV is substantial, and the target CPA is relatively low. However, these cases are the exception rather than the rule.


Your business stage is another important consideration. New companies in growth markets might spend 10 to 20 times their CPA to establish themselves in the industry. This is justifiable because they often need to build brand recognition, gather initial data, and create a customer base from scratch, which requires greater upfront risk. In contrast, businesses in mature markets tend to maintain more moderate and targeted spending.


Budget allocation is equally crucial. Not all platforms offer the same ROI, and your strategy must be adjusted based on historical results. For instance, a business consistently seeing strong performance on Google Ads might allocate 60% of its budget there while exploring platforms like Meta Ads with the remaining 40%.


Finally, continuous testing is essential. An initial budget should be designed to collect sufficient data. As you gather insights on what works best for your audience, you can redirect resources to the most effective tactics and channels.


Once your campaign is running, increasing the budget will force the system to explore new audiences, which can destabilise the initial learning phase of your campaigns. This happens because the algorithm must test segments that may not be as effective as the original ones, leading to fluctuations in conversion rates and CPA while the campaign identifies new high-potential audiences.


This adjustment period may result in temporarily inconsistent performance as you expand into audiences with lower purchase intent. To avoid a significant negative impact on performance, gradually increasing the budget—ideally no more than 20% at a time—allows the system to adapt without resetting the learning phase. Accounts with larger budgets tend to manage this risk better, as campaigns have a greater capacity to run rapid tests and validate new channels with more flexibility.


Investing in paid media is about balancing investment and return with a strategic, data-driven approach. Prioritise analysing metrics such as CPA and CLTV, adjust according to your business stage, and never underestimate the importance of constant testing and learning.


On the dynamic path to digitalization in the pharmaceutical industry, much can be learned from the success stories being published; unravelling the main lessons can provide great value, especially for those starting in the pharmaceutical e-commerce industry. Today, I'll share some of the lessons I've observed.


Every successful transition to the digital world initially relies on having a solid understanding and experience of the offline business, such as inventory management, customer service, and understanding the needs and preferences of customers. This allows for a smooth and well-informed transition to online.


An intelligent initial step could be starting on established platforms (marketplaces) like Amazon. This provides a learning opportunity to understand best practices, from customer and incident management, to contact with transport companies, before venturing to open your own e-commerce.


One of the biggest challenges in this industry is the strict regulation surrounding the online sale of medicines (Spain is an example), especially those requiring medical prescriptions. This is not only an obstacle, but an opportunity for specialization in less regulated niches like dermocosmetics, allowing companies to compete in the digital market and offer differential value. Some less-regulated categories are cosmetics, supplements, and orthopaedics.


These lessons underline the importance of a well-calculated and informed transition to pharmaceutical e-commerce, highlighting adaptability, specialization, and maintaining a connection with customers as pillars in the digitalization of the pharmaceutical industry.

bottom of page